옥시토신 제제 시장 : 적응증별, 투여 경로별, 원료별, 최종사용자별 및 지역별

Oxytocic Pharmaceuticals Market is estimated to be valued at USD 160.7 Mn in 2026 and is expected to reach USD 275.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.

Market Dynamics

The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Universite to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market

Detailed Segmentation:

• Global Oxytocic Pharmaceuticals Market, By Indication (Revenue, USD Mn, 2021 - 2033)
• Abortion Induced Incomplete
• Inevitable Abortion
• Postpartum Hemorrhage
• Labor Induction
• Labor Arrest
• Global Oxytocic Pharmaceuticals Market, By Route of Administration:
• Intramuscular
• Intravenous Injection/Infusion
• Global Oxytocic Pharmaceuticals Market, By Source of Origin:
• Synthetic Oxytocin
• Natural Oxytocin (Animal Pituitary Extract)
• Global Oxytocic Pharmaceuticals Market, By End User:
• Hospitals
• Maternity Clinics
• Global Oxytocic Pharmaceuticals Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• Fresenius Kabi AG *
• Biofutura SpA
• Baxter Healthcare Corporation
• Pfizer Inc.
• Ferring B.V.
• Abbott.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Abbott
• AdvaCare Pharma
• EVER Pharma

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Indication
  • Market Snippet, By Route of Administration
  • Market Snippet, By Source of Origin
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Oxytocic Pharmaceuticals Market, By Indication, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Abortion Induced Incomplete
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Inevitable Abortion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Postpartum Hemorrhage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Labor Induction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Labor Arrest
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Intravenous Injection/Infusion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Synthetic Oxytocin
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Natural Oxytocin (Animal Pituitary Extract)
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global Oxytocic Pharmaceuticals Market, By End User, 2021 - 2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Maternity Clinics
  • Introduction
  • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

8. Global Oxytocic Pharmaceuticals Market, By Region, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
• North America
  • Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
• Middle East
  • Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

• Company Profiles
  • Fresenius Kabi AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biofutura SpA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Baxter Healthcare Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ferring B.V.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • AdvaCare Pharma
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • EVER Pharma
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies

10. Section

• References
• Research Methodology
• About us and Sales Contact